Eli Lilly In Hot Seat Again Over Zyprexa

Law360, New York (January 22, 2007, 12:00 AM EST) -- Fresh off a $495 million product-liability settlement over Zyprexa, Eli Lilly & Co. is facing more scrutiny, with Illinois and Vermont requesting that the pharmaceutical giant hand over material detailing how it marketed the top-selling schizophrenia drug.

The New York Times reported on Saturday that state prosecutors in both Illinois and Vermont demanded last week that Eli Lilly turn over marketing materials, e-mail messages and other documents regarding Zyprexa’s advertising campaign.

With the requests, the states have now joined a larger, five-state civil investigation into the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.